AQR CAPITAL MANAGEMENT LLC
Position in TLSI — TriSalus Life Sciences, Inc.
CIK 1167557
Greenwich, CT
Position in TLSI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$536,793
New position
Shares Held
117,977
first reported quarter
Ownership
0.192%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 83 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $3,192,742,950 across 81 Medical Devices names. TLSI ranks #74 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
9,681,750 | $413,217,085 | |
| 2 | ABT |
Abbott Laboratories
|
4,193,058 | $380,478,079 | |
| 3 | PODD |
Insulet Corp
|
2,455,135 | $373,794,300 | |
| 4 | STE |
STERIS plc
|
1,377,297 | $290,017,425 | |
| 5 | MDT |
Medtronic plc
|
3,299,627 | $258,129,817 | |
| 6 | DXCM |
Dexcom Inc
|
3,237,720 | $218,060,438 | |
| 7 | LIVN |
LivaNova PLC
|
2,356,191 | $193,749,582 | |
| 8 | HAE |
Haemonetics Corp
|
2,266,489 | $169,986,675 |
All Filings in TLSI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $536,793 | 117,977 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||